Document is current
Any future updates will be listed below
-
Authors
Angiari, Stefano
Carlucci, Tommaso
Budui, Simona L.
Bach, Simone D.
Dusi, Silvia
Walter, Julia
Ellmeier, Elena
Schnabl, Alyssa
Stracke, Anika
Bordag, Natalie
Tafrali, Cansu
Demjaha, Rina
Khalil, Michael
Angelini, Gabriele
Terrabuio, Eleonora
Pietronigro, Enrica C.
Zenaro, Elena
Laudanna, Carlo
Rossi, Barbara
Constantin, Gabriela
-
Funding
Funding for this research was provided by:
Kulturamt der Stadt Graz (FIF-A 16-1140/2022-0001)
Austrian Multiple Sclerosis Research Association
Worldwide Cancer Research (23-0112)
Fondazione Italiana Sclerosi Multipla
National Multiple Sclerosis Society
European Research Council (695714)
Ministero dell'Università e della Ricerca
- License Information
-
More Information
Article History
Received: 21 April 2024
Accepted: 22 October 2024
First Online: 5 November 2024
Declarations
:
: The studies involving mice were authorized by the Italian Ministry of Health, Department of Veterinary Public Health, Nutrition and Food Safety, Directorate-General of Animal Health and Veterinary Medicine, as required by the Italian legislation (D.Lgs 26/2014, application of European Directive 2010/63/EU). Protocol numbers 12269 and 12269.EXT.0 were used for the in vivo studies in this manuscript. For studies on PBMCs from MS patients, all participants gave written informed consent prior to inclusion in the study. The study was registered at under MarkMS, NCT04892134.
: Not applicable.
: The authors declare no competing interests.
